Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19035
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYang, G-
dc.contributor.authorHamadeh, IS-
dc.contributor.authorKatz, J-
dc.contributor.authorRiva, A-
dc.contributor.authorLakatos, P-
dc.contributor.authorBalla, B-
dc.contributor.authorKosa, J-
dc.contributor.authorVaszilko, M-
dc.contributor.authorPelliccioni, GA-
dc.contributor.authorDavis, N-
dc.contributor.authorLangaee, TY-
dc.contributor.authorMoreb, JS-
dc.contributor.authorGong, Y-
dc.date.accessioned2019-08-30T10:46:55Z-
dc.date.available2018-01-01-
dc.date.available2019-08-30T10:46:55Z-
dc.date.issued2017-08-30-
dc.identifier.citationJournal of Bone and Mineral Research, 2018, 33 (1), pp. 91 - 98en_US
dc.identifier.issn0884-0431-
dc.identifier.issnhttp://dx.doi.org/10.1002/jbmr.3285-
dc.identifier.issn1523-4681-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/19035-
dc.description.abstractJournal of Bone and Mineral Research Published by Wiley Periodicals Inc. Osteonecrosis of the jaw (ONJ) is a rare, but serious drug side effect, mainly associated with the use of intravenous (iv) bisphosphonates (BPs). The purpose of this study was to identify genetic variants associated with ONJ in patients of European ancestry treated with iv BPs using whole-exome sequencing (WES). The WES phase 1 included 44 multiple myeloma patients (22 ONJ cases and 22 controls) and WES phase 2 included 17 ONJ patients with solid tumors. Multivariable logistic regression analysis was performed to estimate the odds ratios (ORs) and 95% confidence intervals (CI), adjusting for age, sex, and principal components for ancestry. Meta-analysis of WES phase 1 and 2 was performed to estimate the combined ORs. In silico analyses were then performed to identify expression quantitative loci (eQTL) single-nucleotide polymorphisms (SNPs) that are in high linkage disequilibrium (LD) with the top SNPs. The associations of the potentially functional SNPs were replicated and validated in an independent case-control study of 48 patients of European ancestry treated with iv BPs (19 ONJ cases and 29 controls). The top SNPs in the exome-wide association meta-analysis were two SNPs on chromosome 10: SIRT1 SNP rs7896005 and HERC4 SNP rs3758392 with identical OR of 0.07 (0.01–0.46; p = 3.83 × 10−5). In the in silico functional analyses, two promoter region SNPs (rs7894483 and rs3758391) were identified to be in high LD with the index SNPs and are eQTLs for SIRT1 gene in whole blood in the GTEx database. The ORs were 0.30 (0.10–0.88), 0.26 (0.12–0.55), and 0.26 (0.12–0.55) for the WES top SNP rs7896005 and two promoter SNPs rs7894483 and rs3758391, respectively, in the replication sample. In summary, we identified the SIRT1/HERC4 locus on chromosome 10 to be associated with iv BP-induced ONJ and two promoter SNPs that might be the potential genetic markers for this association. © 2017 The Authors.Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.en_US
dc.format.extent91 - 98-
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectOSTEONECROSIS OF THE JAW;en_US
dc.subjectWHOLE-EXOME SEQUENCING;en_US
dc.subjectSIRT1 GENE;en_US
dc.subjectPHARMACOGENOMICSen_US
dc.subjectBISPHOSPHONATES;en_US
dc.titleSIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysisen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1002/jbmr.3285-
dc.relation.isPartOfJournal of Bone and Mineral Research-
pubs.issue1-
pubs.publication-statusPublished-
pubs.volume33-
dc.identifier.eissn1523-4681-
Appears in Collections:Dept of Economics and Finance Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.01 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.